Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	OLIENA Language recovery after stroke App | Video | PDF (278 pp) | Web

Pulmonary Hypertension, April 2019 Free Subscription Abstracts Retrieve all available abstracts of the following 115 articles: HTML format

Single Articles

1. GHIO S, D'Alto M, Badagliacca R, Vizza CD, et al
   Pulmonary hypertension in left heart disease: The need to continue to explore.
   Int J Cardiol. 2019 Mar 17. pii: S0167-5273(19)30571.
   Abstract    
   
   
   
   

2. ATIK E, Barreto AC, Binotto MA
   Case 2 / 2019 - Complete Atrioventricular Septal Defect, with Down Syndrome, without Pulmonary Hypertension and Natural History at 33 Years of Age.
   Arq Bras Cardiol. 2019;112:319-320.
   Abstract    
   
   
   
   

3. ZUCKER MM, Wujak L, Gungl A, Didiasova M, et al
   LRP1 promotes synthetic phenotype of pulmonary artery smooth muscle cells in pulmonary hypertension.
   Biochim Biophys Acta Mol Basis Dis. 2019 Mar 22. pii: S0925-4439(19)30086.
   Abstract    
   
   Abstract available
   
   

4. SHAHIN Y, Rothman AM
   Commentary on: evaluation of a newly developed 2D parametric parenchymal blood flow technique with an automated vessel suppression algorithm in patients with chronic thromboembolic pulmonary hypertension undergoing balloon pulmonary angioplasty.
   Clin Radiol. 2019 Mar 22. pii: S0009-9260(19)30122.
   Abstract    
   
   
   
   

5. FUSO L, Pitocco D, Antonelli Incalzi R
   Diabetic lung, an underrated complication from restrictive functional pattern to pulmonary hypertension.
   Diabetes Metab Res Rev. 2019 Mar 25:e3159. doi: 10.1002/dmrr.3159.
   Abstract    
   
   Abstract available
   
   

6. KATZ MG, Fargnoli AS, Gubara SM, Bisserier M, et al
   The Left Pneumonectomy Combined with Monocrotaline or Sugen as a Model of Pulmonary Hypertension in Rats.
   J Vis Exp. 2019;.
   Abstract    
   
   Abstract available
   
   

7. EYUBOGLU M
   The complexity of pulmonary hypertension.
   Hemodial Int. 2019 Mar 24. doi: 10.1111/hdi.12755.
   Abstract    
   
   
   
   

8. KROGER JR, Gerhardt F, Dumitrescu D, Rosenkranz S, et al
   Diagnosis of pulmonary hypertension using spectral-detector CT.
   Int J Cardiol. 2019 Mar 13. pii: S0167-5273(18)35867.
   Abstract    
   
   Abstract available
   
   

9. MIYANAGA S, Kubota K, Iwatani N, Higo K, et al
   Predictors of exercise-induced pulmonary hypertension in patients with connective tissue disease.
   Heart Vessels. 2019 Mar 23. pii: 10.1007/s00380-019-01373.
   Abstract    
   
   Abstract available
   
   

10. HAN H, Francis JK, Spitzer Y, Reddy S, et al
    Anesthetic management of parturients with pulmonary hypertension undergoing cesarean deliveries.
    J Clin Anesth. 2019;57:79.
    Abstract    
    
    
    
    

11. WOO KV, Ornitz DM, Singh GK
    Diagnosis and Pathophysiological Mechanisms of Group 3 Hypoxia-Induced Pulmonary Hypertension.
    Curr Treat Options Cardiovasc Med. 2019;21:16.
    Abstract    
    
    Abstract available
    
    

12. NEIVA J, Fernandes G, Carvalho D, Ferreira B, et al
    Thyroid storm and myxoedema: two reversible causes of acute heart failure.
    Acute Med. 2018;17:229-231.
    Abstract    
    
    Abstract available
    
    

13. MATSUMOTO T, Tamiya E, Kanoh T, Takabe T, et al
    Atrial Septal Defect of the Ostium Secundum Type in A 101-Year-Old Patient.
    Int Heart J. 2019;60:489-491.
    Abstract    
    
    Abstract available
    
    

14. MINATSUKI S, Takeda N, Soma K, Katoh M, et al
    Murine Model of Pulmonary Artery Overflow Vasculopathy Revealed Macrophage Accumulation in the Lung.
    Int Heart J. 2019;60:451-456.
    Abstract    
    
    Abstract available
    
    

15. FUKUOKA K, Aizawa K, Sugaya A, Kawada M, et al
    [Idiopathic Pulmonary Artery Aneurysm].
    Kyobu Geka. 2018;71:1088-1091.
    Abstract    
    
    Abstract available
    
    

16. GUNTHER S, Bordenave J, Hua-Huy T, Nicco C, et al
    Macrophage Migration Inhibitory Factor (MIF) Inhibition in a Murine Model of Bleomycin-Induced Pulmonary Fibrosis.
    Int J Mol Sci. 2018;19.
    Abstract    
    
    Abstract available
    
    

17. SATOH K, Kikuchi N, Satoh T, Kurosawa R, et al
    Identification of Novel Therapeutic Targets for Pulmonary Arterial Hypertension.
    Int J Mol Sci. 2018;19.
    Abstract    
    
    Abstract available
    
    

18. HUANG C, Yang J, Li MT, Wang Q, et al
    CBLN2 rs2217560 was Associated with Pulmonary Arterial Hypertension in Systemic Lupus Erythematosus.
    Chin Med J (Engl). 2018;131:3020-3021.
    Abstract    
    
    
    
    

19. AGGARWAL S, Shanti C, Lelli J, Natarajan G, et al
    Prognostic utility of noninvasive estimates of pulmonary vascular compliance in neonates with congenital diaphragmatic hernia.
    J Pediatr Surg. 2018 Sep 9. pii: S0022-3468(18)30565.
    Abstract    
    
    Abstract available
    
    

20. DUAN L, Hu GH, Li YJ, Zhang CL, et al
    P2X7 receptor is involved in lung injuries induced by ischemia-reperfusion in pulmonary arterial hypertension rats.
    Mol Immunol. 2018;101:409-418.
    Abstract    
    
    Abstract available
    
    

21. AGUERO J, Hammoudi N, Bikou O, Fish KM, et al
    Chronic Pulmonary Artery Embolization Models in Large Animals.
    Methods Mol Biol. 2018;1816:353-366.
    Abstract    
    
    Abstract available
    
    

22. BUENO-BETI C, Hadri L, Hajjar RJ, Sassi Y, et al
    The Sugen 5416/Hypoxia Mouse Model of Pulmonary Arterial Hypertension.
    Methods Mol Biol. 2018;1816:243-252.
    Abstract    
    
    Abstract available
    
    

23. BUENO-BETI C, Sassi Y, Hajjar RJ, Hadri L, et al
    Pulmonary Artery Hypertension Model in Rats by Monocrotaline Administration.
    Methods Mol Biol. 2018;1816:233-241.
    Abstract    
    
    Abstract available
    
    

24. SANDNER P
    From molecules to patients: exploring the therapeutic role of soluble guanylate cyclase stimulators.
    Biol Chem. 2018;399:679-690.
    Abstract    
    
    Abstract available
    
    

25. GOUMANS MJ, Zwijsen A, Ten Dijke P, Bailly S, et al
    Bone Morphogenetic Proteins in Vascular Homeostasis and Disease.
    Cold Spring Harb Perspect Biol. 2018;10.
    Abstract    
    
    Abstract available
    
    

26. GOUMANS MJ, Ten Dijke P
    TGF-beta Signaling in Control of Cardiovascular Function.
    Cold Spring Harb Perspect Biol. 2018;10.
    Abstract    
    
    Abstract available
    
    

27. HUDALLA H, Michael Z, Christodoulou N, Willis GR, et al
    Carbonic Anhydrase Inhibition Ameliorates Inflammation and Experimental Pulmonary Hypertension.
    Am J Respir Cell Mol Biol. 2019 Apr 5. doi: 10.1165/rcmb.2018-0232.
    Abstract    
    
    Abstract available
    
    

28. SHARMA A, Navalkele P, Desai J, Agarwal P, et al
    Hydrops Fetalis and Persistent Pulmonary Hypertension in a Neonate with Anti-E Alloimmunization.
    Case Rep Obstet Gynecol. 2019;2019:3736870.
    Abstract    
    
    Abstract available
    
    

29. CHEN L, Wang N, Peng B, He W, et al
    Pulmonary Artery Denervation: An Alternative Therapy for Pulmonary Hypertension.
    JACC Cardiovasc Interv. 2019;12:691-692.
    Abstract    
    
    
    
    

30. REN X, Johns RA, Gao WD
    EXPRESS: Right Heart in Pulmonary Hypertension: From Adaptation to Failure.
    Pulm Circ. 2019 Apr 3:2045894019845611. doi: 10.1177/2045894019845611.
    Abstract    
    
    
    
    

31. ZHANG M, Zhang YX, Pang W, Zhai Z, et al
    EXPRESS: Circulating biomarkers in chronic thromboembolic pulmonary hypertension.
    Pulm Circ. 2019 Apr 3:2045894019844480. doi: 10.1177/2045894019844480.
    Abstract    
    
    
    
    

32. RADCHENKO GG, Zhyvilo IO, Sirenko YM
    EXPRESS: ANALYSIS OF PULMONARY HYPERTENSION PATIENT SURVIVAL AFTER TREATMENT IN REFERRAL CENTER (DATA OF FIRST UKRAINIAN REGISTER).
    Pulm Circ. 2019 Apr 3:2045894019845604. doi: 10.1177/2045894019845604.
    Abstract    
    
    
    
    

33. ZHU Z, Godana D, Li A, Rodriguez B, et al
    EXPRESS: Echocardiographic Assessment of Right Ventricular Functions in Experimental Pulmonary Hypertension.
    Pulm Circ. 2019 Apr 3:2045894019841987. doi: 10.1177/2045894019841987.
    Abstract    
    
    
    
    

34. CERVI A, Douketis JD
    Prevalence of antiphospholipid antibodies among patients with chronic thromboembolic pulmonary hypertension.
    Intern Emerg Med. 2019 Apr 1. pii: 10.1007/s11739-019-02078.
    Abstract    
    
    
    
    

35. BEHERE S, Alapati D, McCulloch MA
    Screening Echocardiography and Brain Natriuretic Peptide Levels Predict Late Pulmonary Hypertension in Infants with Bronchopulmonary Dysplasia.
    Pediatr Cardiol. 2019 Apr 1. pii: 10.1007/s00246-019-02100.
    Abstract    
    
    Abstract available
    
    

36. MAGON W, Stepniewski J, Waligora M, Jonas K, et al
    Pulmonary Artery Elastic Properties After Balloon Pulmonary Angioplasty in Patients With Inoperable Chronic Thromboembolic Pulmonary Hypertension.
    Can J Cardiol. 2019;35:422-429.
    Abstract    
    
    Abstract available
    
    

37. ZHANG CF, Zhao FY, Xu SL, Liu J, et al
    Autophagy in pulmonary hypertension: Emerging roles and therapeutic implications.
    J Cell Physiol. 2019 Apr 1. doi: 10.1002/jcp.28531.
    Abstract    
    
    Abstract available
    
    

38. HUSTON JH, Frantz R, Brittain E
    EXPRESS: Early Intervention: Should We Conduct Therapeutic Trials For Mild Pulmonary Hypertension Before Onset of Symptoms?
    Pulm Circ. 2019 Apr 1:2045894019844994. doi: 10.1177/2045894019844994.
    Abstract    
    
    
    
    

39. HUR DJ, Sugeng L
    Non-invasive Multimodality Cardiovascular Imaging of the Right Heart and Pulmonary Circulation in Pulmonary Hypertension.
    Front Cardiovasc Med. 2019;6:24.
    Abstract    
    
    Abstract available
    
    

40. CHEN ZW, Chen CW, Wu CK, Hsu HH, et al
    Balloon Pulmonary Angioplasty in Chronic Pulmonary Thromboembolic Pulmonary Hypertension.
    Acta Cardiol Sin. 2019;35:183-187.
    Abstract    
    
    
    
    

41. CHEN YJ, Ho CT, Tsai FC, Lin CP, et al
    Outcomes of Pulmonary Endarterectomy for Chronic Thromboembolic Pulmonary Hypertension at a Single Center in Taiwan.
    Acta Cardiol Sin. 2019;35:153-164.
    Abstract    
    
    Abstract available
    
    

42. GOPAL DM, Ayalon N, Wang YC, Siwik D, et al
    Galectin-3 Is Associated With Stage B Metabolic Heart Disease and Pulmonary Hypertension in Young Obese Patients.
    J Am Heart Assoc. 2019;8:e011100.
    Abstract    
    
    Abstract available
    
    

43. KOJIMA H, Tokunou T, Takahara Y, Sunagawa K, et al
    Hypoxia-inducible factor-1 alpha deletion in myeloid lineage attenuates hypoxia-induced pulmonary hypertension.
    Physiol Rep. 2019;7:e14025.
    Abstract    
    
    Abstract available
    
    

44. YIN TJ, Hu YS, Cheng S, Yong QJ, et al
    Dynamic changes of pulmonary arterial pressure in perinatal neonates with pulmonary and extrapulmonary acute lung injury/respiratory distress syndrome.
    Medicine (Baltimore). 2019;98:e14830.
    Abstract    
    
    Abstract available
    
    

45. FARHAT N, Lador F, Beghetti M
    Diagnosis and treatment of pediatric pulmonary arterial hypertension.
    Expert Rev Cardiovasc Ther. 2019;17:161-175.
    Abstract    
    
    Abstract available
    
    

46. BAN Y, Liu Y, Li Y, Zhang Y, et al
    S-nitrosation impairs KLF4 activity and instigates endothelial dysfunction in pulmonary arterial hypertension.
    Redox Biol. 2019;21:101099.
    Abstract    
    
    Abstract available
    
    

47. DORNELES RG, Plachi F, Gass R, Toniazzo VT, et al
    Sensory consequences of critical inspiratory constraints during exercise in pulmonary arterial hypertension.
    Respir Physiol Neurobiol. 2019;261:40-47.
    Abstract    
    
    Abstract available
    
    

48. IMOTO K, Okada M, Yamawaki H
    Periostin Mediates Right Ventricular Failure through Induction of Inducible Nitric Oxide Synthase Expression in Right Ventricular Fibroblasts from Monocrotaline-Induced Pulmonary Arterial Hypertensive Rats.
    Int J Mol Sci. 2018;20.
    Abstract    
    
    Abstract available
    
    

49. GHANI AR, Hamid M, Dhillon P, Ullah W, et al
    Tilting the balance: hemidiaphragm paralysis leading to right to left cardiac shunt.
    BMJ Case Rep. 2018;11.
    Abstract    
    
    Abstract available
    
    

50. HAN J, Tian H, Liu Y, Fan F, et al
    Sarpogrelate attenuates pulmonary arterial hypertension via calcium/calcineurin axis.
    Front Biosci (Landmark Ed). 2019;24:607-615.
    Abstract    
    
    Abstract available
    
    

51. LI J, Zhuang Q, Zhang X, Zheng Y, et al
    Prevalence and Prognosis of Portopulmonary Hypertension in 223 Liver Transplant Recipients.
    Can Respir J. 2018;2018:9629570.
    Abstract    
    
    Abstract available
    
    

52. HENROHN D, Bjorkstrand K, Lundberg JO, Granstam SO, et al
    Effects of Oral Supplementation With Nitrate-Rich Beetroot Juice in Patients With Pulmonary Arterial Hypertension-Results From BEET-PAH, an Exploratory Randomized, Double-Blind, Placebo-Controlled, Crossover Study.
    J Card Fail. 2018;24:640-653.
    Abstract    
    
    Abstract available
    
    

53. BALMAIN BN, Seale H, Harris J, Hall K, et al
    Relating exercise-induced desaturation and gas-exchange in pulmonary artery hypertension.
    Respir Physiol Neurobiol. 2019;259:58-62.
    Abstract    
    
    Abstract available
    
    

54. SHI ZL, Fang K, Li ZH, Ren DH, et al
    EZH2 Inhibition Ameliorates Transverse Aortic Constriction-Induced Pulmonary Arterial Hypertension in Mice.
    Can Respir J. 2018;2018:9174926.
    Abstract    
    
    Abstract available
    
    

55. GONG SG, Wang L, Pudasaini B, Yuan P, et al
    Transition from Ambrisentan to Bosentan in Pulmonary Arterial Hypertension: A Single-Center Prospective Study.
    Can Respir J. 2018;2018:9836820.
    Abstract    
    
    Abstract available
    
    

56. KIDO T, Nishigaki K, Kawahira Y, Kagisaki K, et al
    Cardiac surgical strategy for extremely low-birthweight infants with pulmonary overcirculation.
    Interact Cardiovasc Thorac Surg. 2018;26:840-844.
    Abstract    
    
    Abstract available
    
    

57. KUMAR VHS, Wang H, Kishkurno S, Paturi BS, et al
    Long-Term Effects of Neonatal Hyperoxia in Adult Mice.
    Anat Rec (Hoboken). 2018;301:717-726.
    Abstract    
    
    Abstract available
    
    

58. RAVIKUMAR N, Gooya A, Cimen S, Frangi AF, et al
    Group-wise similarity registration of point sets using Student's t-mixture model for statistical shape models.
    Med Image Anal. 2018;44:156-176.
    Abstract    
    
    Abstract available
    
    

59. BAUSEWEIN C, Schunk M, Schumacher P, Dittmer J, et al
    Breathlessness services as a new model of support for patients with respiratory disease.
    Chron Respir Dis. 2018;15:48-59.
    Abstract    
    
    Abstract available
    
    

60. SUGIYAMA K, Suzuki S, Maruno K, Fujiyoshi T, et al
    Pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension with active Crohn's disease.
    Surg Case Rep. 2019;5:59.
    Abstract    
    
    Abstract available
    
    

61. BANDYOPADHYAY D, Devanabanda AR, Hajra A, Tummala R, et al
    Impact of pulmonary hypertension in patients undergoing atrial fibrillation ablation: A nationwide study.
    Int J Cardiol Heart Vasc. 2019;23:100348.
    Abstract    
    
    
    
    

62. SHIMODA LA
    CA Dreamin': Carbonic Anhydrase Inhibitors, Macrophages and Pulmonary Hypertension.
    Am J Respir Cell Mol Biol. 2019 Apr 11. doi: 10.1165/rcmb.2019-0122.
    Abstract    
    
    
    
    

63. SUN WL, Wang JL, Jia GH, Mi WJ, et al
    Impact of obstructive sleep apnea on pulmonary hypertension in patients with chronic obstructive pulmonary disease.
    Chin Med J (Engl). 2019 Apr 3. doi: 10.1097/CM9.0000000000000247.
    Abstract    
    
    Abstract available
    
    

64. UCHIYAMA N, Yuasa T, Miyata M, Horizoe Y, et al
    Correlation of Right Ventricular Wall Stress With Plasma B-Type Natriuretic Peptide Levels in Patients With Pulmonary Hypertension.
    Circ J. 2019 Apr 9. doi: 10.1253/circj.CJ-18-1155.
    Abstract    
    
    Abstract available
    
    

65. DATT V, Khurana P, Aggarwal S, Mishra S, et al
    Perioperative management of a patient with double orifice mitral valve with supramitral ring with subaortic membrane with ventricular septal defect and severe pulmonary hypertension: Report of a rare case.
    Ann Card Anaesth. 2019;22:215-220.
    Abstract    
    
    Abstract available
    
    

66. ABDELAZZIZ MM, Abdelhamid HM
    Terlipressin versus norepinephrine to prevent milrinone-induced systemic vascular hypotension in cardiac surgery patient with pulmonary hypertension.
    Ann Card Anaesth. 2019;22:136-142.
    Abstract    
    
    Abstract available
    
    

67. MELZIG C, Worz S, Egenlauf B, Partovi S, et al
    Combined automated 3D volumetry by pulmonary CT angiography and echocardiography for detection of pulmonary hypertension.
    Eur Radiol. 2019 Apr 8. pii: 10.1007/s00330-019-06188.
    Abstract    
    
    Abstract available
    
    

68. BERLIER C, Schwarz EI, Saxer S, Lichtblau M, et al
    Real-Life Experience with Selexipag as an Add-On Therapy to Oral Combination Therapy in Patients with Pulmonary Arterial or Distal Chronic Thromboembolic Pulmonary Hypertension: A Retrospective Analysis.
    Lung. 2019 Apr 8. pii: 10.1007/s00408-019-00222.
    Abstract    
    
    Abstract available
    
    

69. KONDO T, Okumura N, Adachi S, Murohara T, et al
    Editors' Choice Pulmonary Hypertension: Diagnosis, Management, and Treatment.
    Nagoya J Med Sci. 2019;81:19-30.
    Abstract    
    
    Abstract available
    
    

70. PETRAUSKAS LA, Saketkoo LA, Kazecki T, Saito S, et al
    Use of red cell distribution width in a population at high risk for pulmonary hypertension.
    Respir Med. 2019;150:131-135.
    Abstract    
    
    Abstract available
    
    

71. AWERBACH JD, Stackhouse KA, Lee J, Dahhan T, et al
    Outcomes of lung disease-associated pulmonary hypertension and impact of elevated pulmonary vascular resistance.
    Respir Med. 2019;150:126-130.
    Abstract    
    
    Abstract available
    
    

72. ESCRIBANO-SUBIAS P, Bendjenana H, Curtis P, Lang I, et al
    EXPRESS: Ambrisentan for treatment of inoperable chronic thromboembolic pulmonary hypertension (CTEPH).
    Pulm Circ. 2019 Apr 8:2045894019846433. doi: 10.1177/2045894019846433.
    Abstract    
    
    
    
    

73. FINSTERER J
    Pulmonary hypertension may be secondary in carriers of compound heterozygous FOXRED1 variants.
    Mol Genet Metab Rep. 2019;19:100468.
    Abstract    
    
    
    
    

74. HUMBERT M, Galie N, McLaughlin VV, Rubin LJ, et al
    An insider view on the World Symposium on Pulmonary Hypertension.
    Lancet Respir Med. 2019 Apr 4. pii: S2213-2600(19)30111.
    Abstract    
    
    
    
    

75. KIM D, George MP
    Pulmonary Hypertension.
    Med Clin North Am. 2019;103:413-423.
    Abstract    
    
    Abstract available
    
    

76. WANG Y, Dai S, Cheng X, Prado E, et al
    Notch3 signaling activation in smooth muscle cells promotes extrauterine growth restriction-induced pulmonary hypertension.
    Nutr Metab Cardiovasc Dis. 2019 Mar 13. pii: S0939-4753(19)30086.
    Abstract    
    
    Abstract available
    
    

77. MALAHFJI M, Arain S
    Reversed Pulsus Paradoxus in Right Ventricular Failure.
    Methodist Debakey Cardiovasc J. 2018;14:298-300.
    Abstract    
    
    Abstract available
    
    

78. YU X, Zhang Y, Luo Q, Liu Z, et al
    Iron deficiency in pulmonary arterial hypertension associated with congenital heart disease.
    Scand Cardiovasc J. 2018;52:378-382.
    Abstract    
    
    Abstract available
    
    

79. NAITO A, Sakao S, Lang IM, Voelkel NF, et al
    Endothelial cells from pulmonary endarterectomy specimens possess a high angiogenic potential and express high levels of hepatocyte growth factor.
    BMC Pulm Med. 2018;18:197.
    Abstract    
    
    Abstract available
    
    

80. KHIRFAN G, Tonelli AR, Ramsey J, Sahay S, et al
    Palliative care in pulmonary arterial hypertension: an underutilised treatment.
    Eur Respir Rev. 2018;27.
    Abstract    
    
    Abstract available
    
    

81. CLERCX C, Fastres A, Roels E
    Idiopathic pulmonary fibrosis in West Highland white terriers: An update.
    Vet J. 2018;242:53-58.
    Abstract    
    
    Abstract available
    
    

82. AVAZMOHAMMADI R, Mendiola EA, Soares JS, Li DS, et al
    A Computational Cardiac Model for the Adaptation to Pulmonary Arterial Hypertension in the Rat.
    Ann Biomed Eng. 2019;47:138-153.
    Abstract    
    
    Abstract available
    
    

83. MISUMI K, Ogo T, Ueda J, Tsuji A, et al
    Development of Pulmonary Arterial Hypertension in a Patient Treated with Qing-Dai (Chinese Herbal Medicine).
    Intern Med. 2019;58:395-399.
    Abstract    
    
    Abstract available
    
    

84. BADAGLIACCA R, Papa S, Poscia R, Pezzuto B, et al
    The importance of right ventricular function in patients with pulmonary arterial hypertension.
    Expert Rev Respir Med. 2018;12:809-815.
    Abstract    
    
    Abstract available
    
    

85. YORIFUJI K, Uemura Y, Horibata S, Tsuji G, et al
    CHST3 and CHST13 polymorphisms as predictors of bosentan-induced liver toxicity in Japanese patients with pulmonary arterial hypertension.
    Pharmacol Res. 2018;135:259-264.
    Abstract    
    
    Abstract available
    
    

86. RIBEIRO BAPTISTA B, Petitpain N, Gomez E, Yelehe-Okouma M, et al
    Pulmonary arterial hypertension in patient treated for multiple sclerosis with 4-aminopyridine.
    Fundam Clin Pharmacol. 2019;33:127-129.
    Abstract    
    
    Abstract available
    
    

87. WADA H, Nakajima T, Suzuki H, Anazawa R, et al
    Pulmonary capillary hemangiomatosis diagnosed by pathology of explanted lungs: a unique etiology serves as a key of clinical diagnosis.
    Gen Thorac Cardiovasc Surg. 2019;67:332-335.
    Abstract    
    
    Abstract available
    
    

88. MAZIMBA S, Welch TS, Mwansa H, Breathett KK, et al
    Haemodynamically Derived Pulmonary Artery Pulsatility Index Predicts Mortality in Pulmonary Arterial Hypertension.
    Heart Lung Circ. 2019;28:752-760.
    Abstract    
    
    Abstract available
    
    

89. SUNDARAM SM, Chung L
    An Update on Systemic Sclerosis-Associated Pulmonary Arterial Hypertension: a Review of the Current Literature.
    Curr Rheumatol Rep. 2018;20:10.
    Abstract    
    
    Abstract available
    
    

90. DOGAN M, Efe TH, Cimen T, Ozisler C, et al
    Pulmonary Arterial Hemodynamic Assessment by a Novel Index in Systemic Sclerosis Patients: Pulmonary Pulse Transit Time.
    Lung. 2018;196:173-178.
    Abstract    
    
    Abstract available
    
    

91. CONG LH, Du SY, Wu YN, Liu Y, et al
    Upregulation of Klotho potentially inhibits pulmonary vascular remodeling by blocking the activation of the Wnt signaling pathway in rats with PM2.5-induced pulmonary arterial hypertension.
    J Cell Biochem. 2018;119:5581-5597.
    Abstract    
    
    Abstract available
    
    

92. MUTLAK D, Lessick J, Khalil S, Yalonetsky S, et al
    Tricuspid regurgitation in acute heart failure: is there any incremental risk?
    Eur Heart J Cardiovasc Imaging. 2018;19:993-1001.
    Abstract    
    
    Abstract available
    
    

93. COWIE B, Kluger R
    Oesophageal or transgastric views for estimating mean pulmonary artery pressure with transoesophageal echocardiography: A prospective observational study.
    Eur J Anaesthesiol. 2018;35:349-355.
    Abstract    
    
    Abstract available
    
    

94. SANTOSH S, Chu C, Mwangi J, Narayan M, et al
    Changes in pulmonary artery systolic pressure and right ventricular function in patients with end-stage renal disease on maintenance dialysis.
    Nephrology (Carlton). 2019;24:74-80.
    Abstract    
    
    Abstract available
    
    

95. UDJUS C, Cero FT, Halvorsen B, Behmen D, et al
    Caspase-1 induces smooth muscle cell growth in hypoxia-induced pulmonary hypertension.
    Am J Physiol Lung Cell Mol Physiol. 2019 Mar 25. doi: 10.1152/ajplung.00322.2018
    Abstract    
    
    Abstract available
    
    

96. NISHIHARA T, Yamamoto E, Tokitsu T, Sueta D, et al
    New Definition of Pulmonary Hypertension in Heart Failure with Preserved Ejection Fraction Patients.
    Am J Respir Crit Care Med. 2019 Mar 27. doi: 10.1164/rccm.201901-0148.
    Abstract    
    
    
    
    

97. 
    Erratum: Galectin-3 Promotes Vascular Remodeling and Contributes to Pulmonary Hypertension.
    Am J Respir Crit Care Med. 2018;198:824.
    Abstract    
    
    
    
    

98. ZABINI D, Granton E, Hu Y, Miranda MZ, et al
    Loss of SMAD3 Promotes Vascular Remodeling in Pulmonary Arterial Hypertension via MRTF Disinhibition.
    Am J Respir Crit Care Med. 2018;197:244-260.
    Abstract    
    
    Abstract available
    
    

99. BUDAS GR, Boehm M, Kojonazarov B, Viswanathan G, et al
    ASK1 Inhibition Halts Disease Progression in Preclinical Models of Pulmonary Arterial Hypertension.
    Am J Respir Crit Care Med. 2018;197:373-385.
    Abstract    
    
    Abstract available
    
    

100. MERCURIO V, Mukherjee M, Tedford RJ, Zamanian RT, et al
     Improvement in Right Ventricular Strain with Ambrisentan and Tadalafil Upfront Therapy in Scleroderma-associated Pulmonary Arterial Hypertension.
     Am J Respir Crit Care Med. 2018;197:388-391.
     Abstract    
     
     
     
     

101. WAGNER BD, Babinec AE, Carpenter C, Gonzalez S, et al
     Proteomic Profiles Associated with Early Echocardiogram Evidence of Pulmonary Vascular Disease in Preterm Infants.
     Am J Respir Crit Care Med. 2018;197:394-397.
     Abstract    
     
     
     
     

102. RUBIN LJ
     Assessing Prognosis of Pulmonary Arterial Hypertension in the Therapeutic Era: Importance of Serial Hemodynamic Measurements.
     Circulation. 2018;137:705-706.
     Abstract    
     
     
     
     

103. HEMNES AR, Brittain EL
     Autonomic Nervous System in Pulmonary Arterial Hypertension: Time to Rest and Digest.
     Circulation. 2018;137:925-927.
     Abstract    
     
     
     
     

104. WEATHERALD J, Boucly A, Chemla D, Savale L, et al
     The Prognostic Value of Follow-up Hemodynamic Variables After Initial Management in Pulmonary Arterial Hypertension.
     Circulation. 2017 Oct 25. pii: CIRCULATIONAHA.117.029254.
     Abstract    
     
     Abstract available
     
     

105. HUMBERT M, Farber HW, Ghofrani HA, Benza RL, et al
     Risk Assessment in Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension.
     Eur Respir J. 2019 Mar 28. pii: 13993003.02004-2018.
     Abstract    
     
     Abstract available
     
     

106. GIBBS JSR, Torbicki A
     Proposed new pulmonary hypertension definition: is 4 mm(Hg) worth re-writing medical textbooks?
     Eur Respir J. 2019;53.
     Abstract    
     
     
     
     

107. HOEPER MM, Humbert M
     The new haemodynamic definition of pulmonary hypertension: evidence prevails, finally!
     Eur Respir J. 2019;53.
     Abstract    
     
     
     
     

108. KIM NH, Mayer E
     Pulmonary endarterectomy and the cost of patient refusal.
     Eur Respir J. 2018;52.
     Abstract    
     
     
     
     

109. PICHL A, Sommer N, Bednorz M, Seimetz M, et al
     Riociguat for treatment of pulmonary hypertension in COPD - a translational study.
     Eur Respir J. 2019 Apr 7. pii: 13993003.02445-2018.
     Abstract    
     
     Abstract available
     
     

110. ENDE-VERHAAR YM, Meijboom LJ, Kroft LJM, Beenen LFM, et al
     Usefulness of standard computed tomography pulmonary angiography performed for acute pulmonary embolism for identification of chronic thromboembolic pulmonary hypertension: results of the InShape III study.
     J Heart Lung Transplant. 2019 Mar 15. pii: S1053-2498(19)31424.
     Abstract    
     
     Abstract available
     
     

111. BRAVOS E, Cottin V, Dauphin C, Bouvaist H, et al
     Cancer incidence in patients with pre-capillary pulmonary hypertension.
     J Heart Lung Transplant. 2019 Mar 15. pii: S1053-2498(19)31430.
     Abstract    
     
     
     
     

112. HUMPL T, Honjo O, Temple M, de Perrot M, et al
     Pulmonary endarterectomy in a toddler with chronic thromboembolic pulmonary hypertension after Denver shunt.
     J Thorac Cardiovasc Surg. 2019 Mar 2. pii: S0022-5223(19)30553.
     Abstract    
     
     
     
     

113. LAMBERS C, Kornauth C, Oberndorfer F, Boehm PM, et al
     Mechanism of anti-remodelling action of treprostinil in human pulmonary arterial smooth muscle cells.
     PLoS One. 2018;13:e0205195.
     Abstract    
     
     Abstract available
     
     

114. POWER AS, Norman R, Jones TLM, Hickey AJ, et al
     Mitochondrial function remains impaired in the hypertrophied right ventricle of pulmonary hypertensive rats following short duration metoprolol treatment.
     PLoS One. 2019;14:e0214740.
     Abstract    
     
     Abstract available
     
     

115. HOFFMANN-VOLD AM, Weigt SS, Palchevskiy V, Volkmann E, et al
     Augmented concentrations of CX3CL1 are associated with interstitial lung disease in systemic sclerosis.
     PLoS One. 2018;13:e0206545.
     Abstract    
     
     Abstract available